Manufacturing Off -the- Shelf Cell and Gene Products: Allogenic Vs. Autologous

The international regenerative medicines market – which includes the likes of cell therapies, gene/gene-modified cell therapy and tissue engineering – is growing fast. However, there are many challenges that stand in the way of producing commercialized cell and gene products - whether they are allogenic or autologous. The following application note discusses the challenges and potential solutions to these problems.